SEATTLE--(BUSINESS WIRE)--Nativis, Inc., a life sciences company developing non-invasive, safe and highly effective medical device therapies for cancers and other serious diseases, announced today that Chris Rivera, the company’s president and chief executive officer, will present at the 2016 Life Science Innovation Northwest Conference being held on June 1 and June 2, 2016 at the Washington State Convention Center in Seattle, Wash. His presentation will provide an update on the company’s pre-clinical and clinical progress, strategic vision and near term milestones.
Rivera will also be the host of the first annual Washington Life Science Hall of Fame at the conference, created to recognize pioneers in the life science community within Washington State. For more than half a century, the Hall of Fame has developed many historic healthcare breakthroughs of our time including, bone marrow transplantation, cardiac defibrillators, ultrasound imaging, DNA sequencing and one of the first immunotherapy companies, Immunex.
Life Science Innovation Northwest is dedicated to bringing together world-class innovators in biopharma, medical technology, non-profits, research, global health, digital health, biofuels and veterinary medicine. Public and private investors, investment bankers and industry executives focused on business development and partnering opportunities in life sciences find Life Science Innovation Northwest one of the most productive conferences they attend. For more information, please visit http://www.lifesciencewa.org/?page=LSINW_16.
Rivera is scheduled to present at the Life Science Innovation Northwest Conference on Wednesday, June 1, 2016 at 11:10 a.m. PDT at the Washington State Convention Center in the Medical Technology room 611. The Washington Life Science Hall of Fame will follow at 12:00 p.m. PDT in room 6B.
About Nativis, Inc.
Founded in 2002, Nativis, Inc. is a privately held life sciences company located in Seattle’s South Lake Union biotech neighborhood. Nativis’ mission is to improve the human and animal condition by providing non-invasive, safe and highly effective medical device therapies for cancers and other serious diseases.